VKTXViking TherapeuticsHealth Care
$32.16EarningsOct 28, 2026
1D—1W—1M—3M—1Y—
Market cap$3.7BCompany infoRevenue$0.0052-wk range$23 – $42IndustryBiotechnologyWebsitevikingtherapeutics.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▼ −23.6% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S———
P / FCF———
EV / EBITDA———
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin———
Operating margin———
Net margin———
ROE-87.5%14
-87%
-14%
ROIC-108.3%01
-108%
-10%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009794
0.0
0.0
Net debt / EBITDA———
Current ratio4.729288
Interest coverage-70002.6×01
Per shareTTM, with year-over-year change
Revenue / share$0.00—
EPS (diluted)$-4.66▼ −205%
FCF / share$-3.61▼ −174%
Est. EPS growth (fwd)—